Altre lingue Eli Lilly and Company

Azioni

LLY

US5324571083

Prodotti farmaceutici

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 05/12/2024			Variaz. 5gg	Var. 1 gen.
825,62 ^USD	-0,51%		+4,75%	+41,64%

05:35	Eli Lilly investirà 3 miliardi di dollari per espandere lo stabilimento di produzione del Wisconsin negli Stati Uniti.	MT
05/12	Eli Lilly investirà 3 miliardi di dollari nell'espansione della struttura in Wisconsin	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Eli Lilly to Invest $3 Billion to Expand Wisconsin Manufacturing Facility in US	05:35
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments -- Update	05/12
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound	05/12
Health Care Declines as Biotech Gives Back Some Gains - Health Care Roundup	05/12
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments	05/12
Eli Lilly to Invest $3 Billion in Wisconsin Facility Expansion	05/12
Sector Update: Health Care Stocks Retreat Late Afternoon	05/12
Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars	05/12
Lilly announces $3 billion expansion of its recently acquired manufacturing facility in Wisconsin	05/12
Eli Lilly and Company Announces $3 Billion Expansion of the Kenosha County, Wisconsin, Manufacturing Facility	05/12
Sector Update: Health Care	05/12
Eli Lilly, Pfizer Executives Discuss Cancer Cures With President-Elect Trump	05/12
Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports	05/12
Global markets live: Walt Disney, Eli Lilly, Microsoft, GSK, Shell...	05/12
Eli Lilly's Mounjaro to Be Rolled Out Initially to High-Need Obesity Patients in England	05/12
Eli Lilly collaboration to accelerate biotech manufacturing	05/12
Lilly's Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%	05/12
Wall Street's gravity-defying rally awaits non-farm payrolls verdict	05/12
Dollar General : American Eagle, Coty, Southwest Airlines...les valeurs à suivre aujourd'hui à Wall Street -	05/12
Eli Lilly: le Mounjaro sera déployé au Royaume-Uni auprès de 220 000 patients sur 3 ans	05/12
Cambrex Announces Strategic Agreement with Eli Lilly and Company to Support Biotech Collaborator Manufacturing	05/12
Jupiter cherche un nouveau satellite	05/12
En Direct des Marchés : Amundi lorgnerait Allianz GI, Ipsos renonce à Kantar Media, Wavestone avertit	05/12
UK's NICE to Recommend Eli Lilly's Weight-loss Drug to People with Obesity	05/12
Britain drug-cost watchdog says it will recommend Lilly obesity drug	05/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

Zepbound di Lilly batte Wegovy nella sperimentazione del farmaco per la perdita di peso

04 dicembre 2024 alle 18:13